| 1 |
25231079 | Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: implication in a loss-of-function pathology. | 2014 Sep 18 |
1 |
| 2 |
18208395 | Roles of VCP in human neurodegenerative disorders. | 2008 Feb |
2 |
| 3 |
18715868 | Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP-associated disease. | 2008 Oct 31 |
2 |
| 4 |
18798739 | AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential. | 2008 Dec |
1 |
| 5 |
17584300 | Involvement of valosin-containing protein (VCP)/p97 in the formation and clearance of abnormal protein aggregates. | 2007 Jul |
2 |
| 6 |
16822850 | Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates. | 2006 Aug 15 |
6 |
| 7 |
12938736 | Polyglutamine diseases and molecular chaperones. | 2003 Jun |
1 |
| 8 |
12784666 | [A challenge for revealing common molecular mechanisms underlying neurodegenerative disorders]. | 2002 Nov |
1 |
| 9 |
11598795 | VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. | 2001 Oct |
3 |